Keiichi I. Nakayama

Dr. Keiichi I. Nakayama

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2006 in Nature Reviews Cancer
Verified
Journal Article
Closed access
KNKeiichi I. Nakayama
Keiichi I. Nakayama
KNKeiko Nakayama
Keiko Nakayama

22 April 2004 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MYMasayoshi Yada
Masayoshi Yada
SHShigetsugu Hatakeyama
Shigetsugu Hatakeyama
TKTakumi Kamura
Takumi Kamura
MNMasaaki Nishiyama
Masaaki Nishiyama
RTRyosuke Tsunematsu
Ryosuke Tsunematsu
KNKeiichi I Nakayama
Keiichi I Nakayama
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

2 May 2000 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
KNKeiichi I. Nakayama
Keiichi I. Nakayama
HNHiroyasu Nagahama
Hiroyasu Nagahama
YMYohji A. Minamishima
Yohji A. Minamishima
MMMasaki Matsumoto
Masaki Matsumoto
INIkuo Nakamichi
Ikuo Nakamichi
SHShigetsugu Hatakeyama
Shigetsugu Hatakeyama

4 May 1999 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MKM Kitagawa
M Kitagawa
SHS Hatakeyama
S Hatakeyama
MSM Shirane
M Shirane
MMM Matsumoto
M Matsumoto
NIN Ishida
N Ishida
KNKeiichi I. Nakayama
Keiichi I. Nakayama
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

15 January 2021 in Science
Verified
Journal Article
Closed access
PDF file
YJYoshikazu Johmura
Yoshikazu Johmura
TYTakehiro Yamanaka
Takehiro Yamanaka
SOSatotaka Omori
Satotaka Omori
TWTeh-Wei Wang
Teh-Wei Wang
Yuki SugiuraYuki Sugiura
Yuki Sugiura
MNMakoto Nakanishi
Makoto Nakanishi
Selective destruction of senescent cells: Senescent cells are associated with a variety of age-related medical conditions and thus have been proposed as potential targets for therapy, but we do not yet have a full understanding of the underlying mechanisms. Johmura et al. used RNA interference to screen for enzymes essential to the survival of senescent cells (see the Perspective by Pan and Locasale). The authors identified a key role for glutamine metabolism, particularly the enzyme glutaminase 1, and demonstrated that inhibition of this pathway induced the death of senescent cells. Glutaminase targeting also ameliorated aging-related organ dysfunction and obesity-related disorders in mouse models, suggesting the potential therapeutic value of this approach. Science , this issue p. 265 ; see also p. 234

15 December 2004 in Genes & Development
Verified
Journal Article
Open access
PDF file
TKTakumi Kamura
Takumi Kamura
KMKatsumi Maenaka
Katsumi Maenaka
SKShuhei Kotoshiba
Shuhei Kotoshiba
MMMasaki Matsumoto
Masaki Matsumoto
DKDaisuke Kohda
Daisuke Kohda
KNKeiichi I. Nakayama
Keiichi I. Nakayama
The ECS (Elongin B/C-Cul2/Cul5-SOCS-box protein) complex is a member of a family of ubiquitin ligases that share a Cullin-Rbx module. SOCS-box proteins recruit substrates to the ECS complex and are linked to Cullin-Rbx via Elongin B/C. VHL has been implicated as a SOCS-box protein, but lacks a C-terminal sequence (downstream of the BC box) of the SOCS box. We now show that VHL specifically interacts with endogenous Cul2-Rbx1 in mammalian cells, whereas SOCS-box proteins associate with Cul5-Rbx2. We also identify LRR-1 and FEM1B as proteins that share a region of homology with VHL (the VHL box, including the BC box and downstream residues) and associate with Cul2-Rbx1. ECS complexes can thus be classified into two distinct protein assemblies, that is, those that contain a subunit with a VHL box (composed of the BC box and a downstream Cul2 box) that interacts with Cul2-Rbx1, and those that contain a subunit with a SOCS box (BC box and downstream Cul5 box) that interacts with Cul5-Rbx2. Domain-swapping analyses showed that the specificity of interaction of VHL-box and SOCS-box proteins with Cullin-Rbx modules is determined by the Cul2 and Cul5 boxes, respectively. Finally, RNAi-mediated knockdown of the Cul2-Rbx1 inhibited the VHL-mediated degradation of HIF-2α, whereas knockdown of Cul5-Rbx2 did not affect it. These data suggest that the functions of the Cul2-Rbx1 and Cul5-Rbx2 modules are distinct.